Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q40677442)
Watch
English
Pharmacologically based phase I trials in cancer chemotherapy.
scientific article published on April 1994
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
review article
1 reference
stated in
Europe PubMed Central
title
Pharmacologically based phase I trials in cancer chemotherapy
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
main subject
phase I clinical trial
0 references
author name string
Newell DR
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
publication date
1 April 1994
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
volume
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
page(s)
257-275
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
cites work
Design of enzyme inhibitors using iterative protein crystallographic analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cell-signaling targets for antitumour drug development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin dosage: prospective evaluation of a simple formula based on renal function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of individual human cytochromes P450 in drug metabolism and clinical response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacologically guided phase I clinical trials based upon preclinical drug development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adaptive control with feedback strategies for suramin dosing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EORTC guidelines for phase I trials with single agents in adults. EORTC New Drug Development Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelines. EORTC Pharmacokinetics and Metabolism Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacokinetics-pharmacodynamics of anticancer drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacology and Clinical Toxicity of 4'-Iodo-4'-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: critical evaluation and recommendations for future studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
General guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. Joint Steering Committee of the European Organization for Research and Treatment of Cancer (EORTC) and the Cancer Research Campaign (CRC)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intratumoral pharmacokinetic analysis by 19F-magnetic resonance spectroscopy and cytostatic in vivo activity of gemcitabine (dFdC) in two small cell lung cancer xenografts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part I)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamics in cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anticancer drug screening and discovery in the 1990s: a European perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I and pharmacokinetic study of amphethinile
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930172-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(18)30172-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
PubMed publication ID
8040140
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8040140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040140%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit